← Back to all trials
Completed
NCT05601310
Metabolic Characteristics of Type 2 Diabetes Mellitus Combined With Acute Myocardial Infarction: A Untargeted Metabolomics Study
Conditions: STEMI
Sex: All
Ages: 18 Years – N/A
Enrollment: 82
Sponsor: Beijing Friendship Hospital
Location: China
Summary
This study is a retrospective case-control study.
In this study, through untargeted metabolomics, investigators identified several specific changed serum metabolites in T2DM patients with or without AMI and their functions/category.
Moreover, researchers selected several endogenous candidate biomarkers with larger fold change for validation in expanded population to find biomarkers which effectively predict the development of STEMI in patients with T2DM.
Eligibility Criteria
Inclusion Criteria:STEMI patients meet the diagnostic criteria of "Guidelines for the Diagnosis and Treatment of Acute ST-segment Elevation Myocardial Infarction (2015)".STMEI patients undergoing emergency PCI should undergo emergency PCI within 12 hours of onset at Beijing Friendship Hospital affiliated to Capital Medical University.All diabetic patients meet the diagnostic criteria for type 2 diabetes.They agreed to be enrolled in the trial and signed the informed consent.Exclusion Criteria:Combined with severe valvular disease or congenital heart disease, hypertension, chronic kidney disease, stroke, hyperlipidemia, previous history of coronary artery disease.Involved in acute infection, severe hepatic dysfunction, tumor, rheumatic immune disease.Incomplete clinical information.
Source: ClinicalTrials.gov (NCT05601310). StuddyBuddy aggregates publicly available trial information.